tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Fortress Biotech price target raised to $4.50 from $4 at Alliance Global
PremiumThe FlyFortress Biotech price target raised to $4.50 from $4 at Alliance Global
29d ago
Fortress Biotech’s Subsidiary Resubmits NDA for CUTX-101
Premium
Company Announcements
Fortress Biotech’s Subsidiary Resubmits NDA for CUTX-101
1M ago
Journey Medical Corporation Reports Strong Q3 2025 Growth
Premium
Company Announcements
Journey Medical Corporation Reports Strong Q3 2025 Growth
1M ago
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
3M ago
Fortress Biotech: Buy Rating Affirmed Amid Strategic Developments and Financial Upside
Premium
Ratings
Fortress Biotech: Buy Rating Affirmed Amid Strategic Developments and Financial Upside
3M ago
Fortress Biotech Receives FDA Response on CUTX-101
Premium
Company Announcements
Fortress Biotech Receives FDA Response on CUTX-101
3M ago
Fortress Biotech’s Strong Financial Prospects Bolstered by Strategic Acquisitions and Product Approvals
PremiumRatingsFortress Biotech’s Strong Financial Prospects Bolstered by Strategic Acquisitions and Product Approvals
4M ago
Fortress Biotech price target lowered to $17 from $26 at H.C. Wainwright
Premium
The Fly
Fortress Biotech price target lowered to $17 from $26 at H.C. Wainwright
4M ago
Fortress Biotech price target lowered to $12 from $15 at Roth Capital
Premium
The Fly
Fortress Biotech price target lowered to $12 from $15 at Roth Capital
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100